North America Diagnostic Tests Market Size, Share, Growth, Trends and Forecast To 2030
The North America Diagnostic Tests Market is experiencing sustained expansion. Valued at USD 98.72 billion in 2024, the market is projected to reach USD 168.45 billion by 2030, growing at a CAGR of 9.30% during 2025–2030. This report provides a comprehensive analysis of market dynamics, segmentation, drivers, challenges, opportunities, and competitive landscape, drawing exclusively from Data Bridge Market Research to deliver strategic insights for stakeholders.
What Are Diagnostic Tests in North America?
Diagnostic tests include a broad spectrum of in vitro and in vivo assays used to detect, monitor, and manage diseases. Key categories:
- Laboratory-based — Clinical chemistry, immunoassays, microbiology, molecular diagnostics (PCR, NGS).
- Point-of-Care (POC) → Rapid tests, portable analyzers.
- Imaging-integrated → Companion diagnostics with radiology.
- At-home / Self-testing → Glucose, pregnancy, COVID/influenza, cholesterol.
North America leads globally due to high healthcare spending, advanced reimbursement, FDA approvals, and strong R&D ecosystem.
Market Size and Growth Projections
Chronic disease prevalence, aging population, and technological adoption drive growth. From a 2024 base of USD 98.72 billion, the market is anticipated to reach USD 168.45 billion by 2030 at 9.30% CAGR.
| Year/Period | Market Value (USD Billion) | CAGR (%) |
|---|---|---|
| Base Year (2024) | 98.72 | - |
| Forecast (2025–2030) | Projected to 168.45 by 2030 | 9.30 |
Source: Data Bridge Market Research
United States holds the dominant share, driven by high testing volume, reimbursement, and innovation. Canada is the fastest-growing country within North America, supported by universal healthcare expansion and public health investments.
Market Segmentation
The market is segmented to uncover high-growth areas:
By Type
- Clinical Chemistry → Largest segment.
- Immunoassays
- Molecular Diagnostics → Fastest-growing.
- Hematology
- Microbiology
- Coagulation
- Others (urinalysis, endocrinology, therapeutic drug monitoring)
By Technology
- PCR / qPCR
- Next-Generation Sequencing (NGS)
- Microarrays
- Mass Spectrometry
- Flow Cytometry
- Others
By Application
- Infectious Diseases → Dominant.
- Oncology
- Cardiology
- Diabetes
- Autoimmune Diseases
- Others (neurology, genetic disorders)
By End User
- Hospitals & Diagnostic Laboratories → Largest.
- Physician Offices / Clinics
- Home Care / Self-testing
- Academic & Research Institutes
- Others
By Country
- United States → Dominant.
- Canada → Fastest-growing.
- Mexico
Key Drivers Fueling Growth
- High Burden of Chronic & Infectious Diseases → Diabetes, CVD, cancer, COVID-19 legacy.
- Aging Population → Increased screening and monitoring needs.
- Technological Advancements — POC, NGS, AI interpretation, multiplex panels.
- Reimbursement & Insurance Coverage — Favorable policies for diagnostics.
- Preventive Healthcare Shift → Early detection and wellness testing.
Challenges and Restraints
- High Cost of Advanced Tests — NGS, companion diagnostics.
- Reimbursement Variability — Coverage gaps for novel tests.
- Regulatory Stringency — FDA/CLIA requirements.
- Lab Workforce Shortages — Skilled technologist constraints.
Opportunities
- Point-of-Care & At-Home Testing Expansion — Rapid diagnostics.
- Precision Medicine & Companion Diagnostics — Oncology, rare diseases.
- Digital Health Integration — Telemedicine-linked testing.
- Emerging Infectious Disease Preparedness — Multiplex panels.
Competitive Landscape
The market is highly competitive, with leaders investing in automation, multiplex assays, and digital integration:
- Abbott Laboratories (U.S.)
- Roche Diagnostics (Switzerland)
- Siemens Healthineers (Germany)
- Danaher Corporation (Beckman Coulter, Cepheid) (U.S.)
- Quest Diagnostics (U.S.)
- Labcorp (U.S.)
- bioMérieux SA (France)
- Thermo Fisher Scientific (U.S.)
- Becton, Dickinson and Company (U.S.)
- bio-Rad Laboratories (U.S.)
- Hologic, Inc. (U.S.)
- QIAGEN (Netherlands)
- PerkinElmer, Inc. (U.S.)
- Ortho Clinical Diagnostics (U.S.)
- Sysmex Corporation (Japan)
Recent developments include Abbott's 2024 Alinity multi-assay system expansions; Roche's 2025 cobas t 711 coagulation analyzer launch; and Labcorp's 2024 at-home testing platform enhancements.
Future Trends and Opportunities
By 2030, trends will emphasize at-home diagnostics, AI/ML interpretation, multiplex panels, and liquid biopsy integration. Opportunities in preventive screening, chronic disease monitoring, and emerging infectious disease preparedness.
Conclusion
The North America Diagnostic Tests Market is set for strong growth to USD 168.45 billion by 2030 at 9.30% CAGR, powering precision healthcare. Stakeholders should invest in POC and molecular solutions to overcome costs and capture preventive testing opportunities. Prioritizing U.S. reimbursement and Canada's public health investments will ensure diagnostic success.
Browse More Reports:
Global Digital Human Market
Global Passion Fruit Market
Global Skin Care Products Market
Global Diagnostic Tests Market
Global eSports Market
South America Tissue Paper Market
Global Propylene Market
Global Biosurfactants Market
Global Paper and Paperboard Packaging Market
Global Hydroxypropyl Methylcellulose (HPMC) Market
Global Protein Cookie Market
Global Hydrophonics Market
Global Aquaponics Market
Global Betanin Market
Global Burglar Alarm Market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email:- corporatesales@databridgemarketresearch.com
Спонсоры
Категории
Больше
In modern healthcare settings, the ability to manage acute cardiovascular events quickly and effectively has become crucial. Medical professionals are focusing heavily on improving procedural response times and adopting therapies that offer immediate clinical impact. The growing demand for rapid-acting injectable medications reflects these priorities, particularly in hospitals where cardiac...
"Executive Summary Pterygium Drug Market Research: Share and Size Intelligence Data Bridge Market Research analyses that the global pterygium drug market will grow at a CAGR of 6.2% during the forecast period of 2022 to 2029. The all-inclusive Pterygium Drug Market report is the best to know the trends and opportunities in Pterygium Drug Market industry. In this report, several...
"Executive Summary Driveline Market Size and Share Analysis Report The global driveline market size was valued at USD 307.66 Million in 2024 and is projected to reach USD 1044.65 Million by 2032, with a CAGR of 16.51% during the forecast period of 2025 to 2032. This Driveline Market report is useful in evaluating the relative efficiency of the different advertising media, selling...
"Executive Summary Slotted Containers Market Size and Share Analysis Report The global slotted containers market size was valued at USD 3.57 billion in 2024 and is expected to reach USD 5.27 billion by 2032, at a CAGR of 5.00% during the forecast period With the use of few steps or the combination of several steps, the process of generating Slotted...
"Latest Insights on Executive Summary Decompression Toys Market Share and Size CAGR Value The decompression toys market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 3,005.6 million by 2028 and grow at a CAGR of 8.2% in the above-mentioned forecast period. This Decompression Toys...
